Sobi's Board of directors exercises its authorisation for repurchase of shares to secure the company’s commitments under the incentive programme
The annual general meeting of Swedish Orphan Biovitrum AB (publ) (Sobi™) on 24 May 2016 resolved – for the purpose of ensuring that the company can fulfill its commitments under the long-term incentive programme resolved by the annual general meeting – on a directed share issue of no more than 188,142 redeemable and convertible class C shares. The general meeting also resolved to authorise the board of directors to resolve on the repurchase of all issued class C shares by an offer directed to all holders of class C shares. Repurchase under this authorisation may be